Logo
SubscribeSign In
LeaderPortfolio
Billionaire Profile
Sun Piaoyang
Global Rank
#247

Image: Unsplash Contributor | Unsplash License | via Unsplash

Sun Piaoyang

CEO, Pharmaceuticals
CHINA
Real-Time Net Worth
$12.042B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+4.29% (24h)
Age
67
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
CHINA

Biography

Sun Piaoyang, a prominent figure in the Chinese pharmaceutical industry, is the chairman of Jiangsu Hengrui Medicine. His estimated net worth is $12.5 billion, placing him among the world's wealthiest individuals. Sun has built his fortune through the strategic leadership of Jiangsu Hengrui Medicine since taking over the state-led company in 1990. Under his guidance, the company has grown into one of China's largest producers of anti-infection and anti-cancer medicines, with a strong emphasis on research and development. His career has been marked by a commitment to innovation and patient-centered solutions in the healthcare sector. Sun's contributions have significantly impacted the Chinese healthcare landscape, fostering advancements in cancer treatment and overall pharmaceutical innovation.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Sun Piaoyang was born in Lianyungang, China, in 1958. He displayed exceptional academic abilities from a young age. He earned a bachelor's degree from China Pharmaceutical University and a doctorate from Nanjing University.

Rise to Success

Sun began his career at the state-run Lianyungang Pharmaceutical Factory. In 1990, he took over the factory, which was later recognized as Jiangsu Hengrui Medicine. Under Sun's leadership, the company transformed into a leading pharmaceutical firm, focusing on anti-infection and anti-cancer medications. The company went public on the Shanghai Stock Exchange in 2000.

Key Business Strategies

Sun's approach has prioritized research and development. His investment in innovation and focus on creating high-impact drugs have set Hengrui apart. This strategy drove the company's expansion into international markets and secured approvals from global regulatory bodies. He also emphasized long-term growth over short-term profits.

Philanthropy

Sun Piaoyang is known for his philanthropy and dedication to societal well-being and healthcare advancement. Further details on specific initiatives are unavailable.

Career Milestones

1990

Took over Jiangsu Hengrui Medicine

Assumed leadership of the state-led Jiangsu Hengrui Medicine, transforming it into a major pharmaceutical company.

2000

Jiangsu Hengrui Medicine went public

Led the company to become listed on the Shanghai Stock Exchange, boosting its financial standing.

2014

FDA approval for injectable drug 'oxaliplatin'

Achieved FDA approval for 'oxaliplatin', which is vital in the treatment of advanced colon cancer, expanded the company's global footprint.

2020

Stepped down as chairman

Resigned as chairman of Jiangsu Hengrui Medicine.

2025

Hong Kong Listing

Led the firm to complete a Hong Kong listing, raising $1.3 billion.

Philanthropy & Social Impact

Healthcare

Healthcare Initiatives

Undisclosed

Supports improving healthcare access and medical research.

Business Philosophy & Leadership

Leadership Principles

Innovation

Focusing on high-impact, innovative drugs and investing heavily in research and development.

Patient-centered Innovation

Addressing critical medical needs, especially for diseases like cancer.

Sustainable Growth

Allocating a significant portion of company revenue to research and development for long-term success.

Global Expansion

Expanding into global markets and forming strategic partnerships.

Compare Sun Piaoyang

Net Worth Face-off
Sun Piaoyang vs Elon Musk
Compare Wealth →
Net Worth Face-off
Sun Piaoyang vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Sun Piaoyang vs Mark Zuckerberg
Compare Wealth →